Clinicopathologic significance of immunophenotypic profiles related to germinal center and activation B-cell differentiation in diffuse large B-cell lymphoma from Chinese patients

Human Pathology

Volumn 39, Issue 6, 2008, Pages 875-884

  Liu, Yan Hui ^a   Xu, Fang Ping ^a   Zhuang, Heng Guo ^a   Lai, Kin Chung Chris ^b   Xie, Dan ^c   Luo, Dong Lan ^a   Li, Li ^a   Luo, Xin Lan ^a   Xu, Jie ^a   Zhang, Ming Hui ^a   Zhang, Fen ^a   Li, Hiu Ming ^b  

^a GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Activated B cell; Diffuse large B cell lymphoma; Germinal center B cell; Immunohistochemistry; Prognostic markers; t(14; 18)

Indexed keywords

COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLIN D3; CYCLIN DEPENDENT KINASE INHIBITOR 1B; GEMININ; INTERFERON REGULATORY FACTOR 4; KI 67 ANTIGEN; PROTEIN BCL 6; SYNDECAN 1;

ADOLESCENT; ADULT; AGED; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; CHILD; CHINESE; CLINICAL FEATURE; FEMALE; GERMINAL CENTER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LARGE CELL LYMPHOMA; LYMPHOCYTE DIFFERENTIATION; PROTEIN EXPRESSION; SURVIVAL TIME; TISSUE MICROARRAY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; B-LYMPHOCYTES; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CHILD; CHILD, PRESCHOOL; CHINA; FEMALE; GERMINAL CENTER; HUMANS; IMMUNOPHENOTYPING; LYMPH NODES; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SURVIVAL RATE; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 44649149489     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2007.10.013     Document Type: Article

References (31)

1. Alizadeh A.A., Eisen M.B., Davis R.E., et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403 (2000) 503-511
2. Shipp M.A., Ross K.N., Tamayo P., et al. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat Med 8 (2002) 68-74
3. Rosenwald A., Wright G., Chan W.C., et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 346 (2002) 1937-1947
4. Wright G., Tan B., Rosenwald A., Hurt E.H., Wiestner A., and Staudt L.M. A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma. Proc Natl Acad Sci U S A 100 (2003) 9991-9996
5. Poulsen C.B., Borup R., Nielsen F.C., et al. Microarray-based classification of diffuse large B-cell lymphoma. Eur J Haematol 74 (2005) 453-465
6. A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 329 (1993) 987-994
7. Hans C.P., Weisenburger D.D., Greiner T.C., et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103 (2004) 275-282
8. Colomo L., Lopez-Guillermo A., Perales M., et al. Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma. Blood 101 (2003) 78-84
9. Chang C.C., McClintock S., Cleveland R.P., et al. Immunohistochemical expression patterns of germinal center and activation B-cell markers correlate with prognosis in diffuse large B-cell lymphoma. Am J Surg Pathol 28 (2004) 464-470
10. Yin H.F., Li T., and Li J.X. Retrospective analysis of 304 cases of malignant lymphomas in pathology: study and practice of the WHO classification of lymphoid neoplasms. Zhonghua Yi Xue Za Zhi 83 (2003) 1556-1560
11. Huang J.Z., Sanger W.G., Greiner T.C., et al. The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell gene expression profile. Blood 99 (2002) 2285-2290
12. Iqbal J., Sanger W.G., Horsman D.E., et al. BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like type of diffuse large B-cell lymphoma. Am J Pathol 165 (2004) 159-166
13. Muris J.J., Meijer C.J., Vos W., et al. Immunohistochemical profiling based on Bcl-2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma. J Pathol 208 (2006) 714-723
14. Berglund M., Thunberg U., Amini R.M., et al. Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis. Mod Pathol 18 (2005) 1113-1120
15. Hans C.P., Weisenburger D.D., Greiner T.C., et al. Expression of PKC-beta or cyclin D2 predicts for inferior survival in diffuse large B-cell lymphoma. Mod Pathol 18 (2005) 1377-1384
16. Sanchez-Beato M., Camacho F.I., Martinez-Montero J.C., et al. Anomalous high p27/KIP1 expression in a subset of aggressive B-cell lymphomas is associated with cyclin D3 overexpression and P27/KIP1-cyclin D3 colocalization in tumor cells. Blood 94 (1999) 765-772
17. Obermann E.C., Eward K.L., Dogan A., et al. DNA replication licensing in peripheral B-cell lymphoma. J Pathol 205 (2005) 318-328
18. Wohlschlegel J.A., Kutok J.L., Weng A.P., and Dutta A. Expression of geminin as a marker of cell proliferation in normal tissues and malignancies. Am J Pathol 161 (2002) 267-273
19. Shia A.K.H., Gan G.G., Jairaman S., and Peh S.C. High frequency of germinal centre derivation in diffuse large B cell lymphoma from Asian patients. J Clin Pathol 58 (2005) 962-967
20. The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood 89 (1997) 3909-3918
21. Sukpanichnant S. Analysis of 1983 cases of malignant lymphoma in Thailand according to the World Health Organization classification. Hum Pathol 35 (2004) 224-230
22. Dogan A., Bagdi E., Munson P., and Isaacson P.G. CD10 and BCL-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas. Am J Surg Pathol 24 (2000) 846-852
23. Ree H.J., Yang W.I., Kim C.W., et al. Coexpression of Bcl-6 and CD10 in diffuse large B-cell lymphomas: significance of Bcl-6 expression patterns in identifying germinal center B-cell lymphoma. Hum Pathol 32 (2001) 954-962
24. Gascoyne R.D., Adomat S.A., Krajewski S., et al. Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma. Blood 90 (1997) 244-251
25. Rantanen S., Monni O., Joensuu H., Franssila K., and Knuutila S. Causes and consequences of Bcl-2 overexpression in diffuse large B cell lymphoma. Leuk Lymphoma 42 (2001) 1089-1098
26. Sanchez-Beato M., Sanchez-Aguilera A., and Piris M.A. Cell cycle deregulation in B-cell lymphomas. Blood 101 (2003) 1220-1235
27. Gonzalez M.A., Tachibana K.E., Chin S.F., et al. Geminin predicts adverse clinical outcome in breast cancer by reflecting cell-cycle progression. J Pathol 204 (2004) 121-130
28. Dudderidge T.J., Stoeber K., Loddo M., et al. Mcm2, geminin, and KI67 define proliferative state and are prognostic markers in renal cell carcinoma. Clin Cancer Res 11 (2005) 2510-2517
29. Miller T.P., Grogan T.M., Dahlberg S., et al. Prognostic significance of the Ki-67-associated proliferative antigen in aggressive non-Hodgkin's lymphomas: a prospective Southwest Oncology Group trial. Blood 83 (1994) 1460-1466
30. Sherr C.J. Cancer cell cycles. Science 274 (1996) 1672-1677
31. Filipits M., Jaeger U., Pohl G., et al. Cyclin D3 is a predictive and prognostic factor in diffuse large B-cell lymphoma. Clin Cancer Res 8 (2002) 729-733